INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 141 filers reported holding INTERSECT ENT INC in Q1 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $15,712,000 | +18.6% | 631,023 | -19.0% | 2.10% | -14.1% |
| Q3 2019 | $13,253,000 | +56.4% | 779,134 | +195.7% | 2.45% | +40.1% |
| Q1 2019 | $8,472,000 | +4.4% | 263,500 | -8.5% | 1.75% | +63.9% |
| Q4 2018 | $8,113,000 | +20.5% | 287,900 | +22.9% | 1.07% | +7.7% |
| Q3 2018 | $6,733,000 | -33.4% | 234,200 | -63.3% | 0.99% | +9.3% |
| Q3 2016 | $10,115,000 | +10.1% | 638,600 | -10.1% | 0.91% | +1.6% |
| Q2 2016 | $9,188,000 | – | 710,600 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |